Masimo (NASDAQ:MASI) Releases FY24 Earnings Guidance

Masimo (NASDAQ:MASI) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $3.95-$4.10 for the period, compared to the consensus estimate of $3.88. The company issued revenue guidance of $2.075-$2.105 billion, compared to the consensus revenue estimate of $2.10 billion. Masimo also updated its Q4 2024 guidance to 1.350-1.500 EPS.

Analyst Ratings Changes

Several research analysts have recently commented on MASI shares. BTIG Research raised their target price on shares of Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a report on Monday, October 14th. Wells Fargo & Company raised their price objective on Masimo from $160.00 to $171.00 and gave the stock an “overweight” rating in a research note on Wednesday. Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a report on Wednesday. Piper Sandler increased their target price on Masimo from $165.00 to $180.00 and gave the stock an “overweight” rating in a report on Wednesday. Finally, Raymond James raised Masimo from a “market perform” rating to an “outperform” rating and set a $170.00 price target for the company in a research note on Wednesday. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $152.57.

Masimo Price Performance

Shares of MASI stock traded down $6.28 on Thursday, hitting $161.35. 952,749 shares of the company’s stock were exchanged, compared to its average volume of 683,751. Masimo has a 12 month low of $75.36 and a 12 month high of $173.90. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.15. The company has a 50 day moving average of $132.63 and a 200 day moving average of $125.88. The stock has a market cap of $8.58 billion, a P/E ratio of 109.76 and a beta of 0.97.

Masimo (NASDAQ:MASI) last announced its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.14. The company had revenue of $504.60 million for the quarter, compared to analyst estimates of $502.87 million. Masimo had a net margin of 3.94% and a return on equity of 14.07%. The firm’s revenue was up 5.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.63 EPS. On average, equities research analysts predict that Masimo will post 3.88 EPS for the current year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.